ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

HQL // abrdn Life Sciences Investors

ANR <GO> NYSE RQD COCKPIT → CIK 0000884121 ↗
Financials • Investment Managers
$17.98 ▼ -0.46 (-2.49%)
MKT CAP: $473.5M • VOL: 79.4K
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8 SELL: 2
12M STREET TARGET RANGE IMPLIED: +14.0%
LOW
$15
MEDIAN
$20
MEAN
$21
HIGH
$24
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100 EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HQL TAPE
HQL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>) CURRENT 90D STREET CONSENSUS
INSTITUTION / ANALYST ACTION RATING TARGET PRIOR PT CALL DATE PX AT CALL RET SINCE CALL 1Y ACCURACY BS GRADE
Morgan Stanley Institutional
Equity Desk
REITERATE OUTPERFORM $21.76 $20.68 2025-02-14 $16.36 +9.9% 78% A
Goldman Sachs Global Research
Sector Coverage
TARGET REV STRONG BUY $22.65 $21.22 2025-02-06 $16.90 +6.4% 74% A
J.P. Morgan Securities
US Large Cap
REITERATE BUY $20.50 $19.78 2025-01-29 $17.26 +4.2% 67% B
Bernstein Autonomous
Forensic Coverage
INITIATE HOLD $18.34 — 2025-01-17 $17.62 +2.0% 61% B
Barclays Capital
Americas Research
DOWNGRADE UNDERPERFORM $15.82 $17.08 2025-01-09 $16.00 -11.2% 42% D
UBS Investment Bank
Institutional Desk
UPGRADE BUY $21.40 $18.70 2024-12-18 $15.64 +14.9% 72% A
Citigroup Global Markets
Sector Lead
TARGET REV HOLD $17.44 $18.16 2024-12-04 $16.72 -4.3% 48% C